vs

Side-by-side financial comparison of GDS Holdings Ltd (GDS) and Royalty Pharma plc (RPRX). Click either name above to swap in a different company.

Royalty Pharma plc is the larger business by last-quarter revenue ($622.0M vs $405.6M, roughly 1.5× GDS Holdings Ltd). Royalty Pharma plc runs the higher net margin — 34.4% vs -0.1%, a 34.5% gap on every dollar of revenue.

Amadeus IT Group, S.A. is a major Spanish multinational technology company that provides software for the global travel and tourism industry. It is the world's leading provider of travel technology that focus on developing software for airlines, hotels, travel agencies, and other travel-related businesses.

Acceleron Pharma, Inc. is an American clinical stage biopharmaceutical company based in Cambridge, Massachusetts with a broad focus on developing medicines that regulate the transforming growth factor beta (TGF-β) superfamily of proteins, which play fundamental roles in the growth and repair of cells and tissues such as red blood cells, muscle, bone, and blood vessels.

GDS vs RPRX — Head-to-Head

Bigger by revenue
RPRX
RPRX
1.5× larger
RPRX
$622.0M
$405.6M
GDS
Higher net margin
RPRX
RPRX
34.5% more per $
RPRX
34.4%
-0.1%
GDS

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
GDS
GDS
RPRX
RPRX
Revenue
$405.6M
$622.0M
Net Profit
$-373.0K
$214.2M
Gross Margin
22.1%
Operating Margin
62.4%
Net Margin
-0.1%
34.4%
Revenue YoY
4.8%
Net Profit YoY
2.9%
EPS (diluted)
$0.49

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
GDS
GDS
RPRX
RPRX
Q4 25
$622.0M
Q3 25
$405.6M
$609.3M
Q2 25
$404.9M
$578.7M
Q1 25
$375.3M
$568.2M
Q4 24
$593.6M
Q3 24
$422.6M
$564.7M
Q2 24
$388.9M
$537.3M
Q1 24
$363.9M
$568.0M
Net Profit
GDS
GDS
RPRX
RPRX
Q4 25
$214.2M
Q3 25
$-373.0K
$288.2M
Q2 25
$-240.0K
$30.2M
Q1 25
$-145.0K
$238.3M
Q4 24
$208.2M
Q3 24
$-32.9M
$544.0M
Q2 24
$-31.9M
$102.0M
Q1 24
$-47.8M
$4.8M
Gross Margin
GDS
GDS
RPRX
RPRX
Q4 25
Q3 25
22.1%
Q2 25
23.8%
Q1 25
23.7%
Q4 24
Q3 24
22.2%
Q2 24
22.6%
Q1 24
21.8%
Operating Margin
GDS
GDS
RPRX
RPRX
Q4 25
62.4%
Q3 25
70.1%
Q2 25
36.3%
Q1 25
94.0%
Q4 24
60.9%
Q3 24
10.8%
Q2 24
11.2%
50.2%
Q1 24
8.3%
-13.0%
Net Margin
GDS
GDS
RPRX
RPRX
Q4 25
34.4%
Q3 25
-0.1%
47.3%
Q2 25
-0.1%
5.2%
Q1 25
-0.0%
41.9%
Q4 24
35.1%
Q3 24
-7.8%
96.3%
Q2 24
-8.2%
19.0%
Q1 24
-13.1%
0.8%
EPS (diluted)
GDS
GDS
RPRX
RPRX
Q4 25
$0.49
Q3 25
$0.67
Q2 25
$0.07
Q1 25
$0.55
Q4 24
$0.46
Q3 24
$1.21
Q2 24
$0.23
Q1 24
$0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
GDS
GDS
RPRX
RPRX
Cash + ST InvestmentsLiquidity on hand
$618.7M
Total DebtLower is stronger
$9.0B
Stockholders' EquityBook value
$3.6B
$9.7B
Total Assets
$11.0B
$19.6B
Debt / EquityLower = less leverage
0.92×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
GDS
GDS
RPRX
RPRX
Q4 25
$618.7M
Q3 25
$938.9M
Q2 25
$631.9M
Q1 25
$1.1B
Q4 24
$929.0M
Q3 24
$950.1M
Q2 24
$1.8B
Q1 24
$843.0M
Total Debt
GDS
GDS
RPRX
RPRX
Q4 25
$9.0B
Q3 25
$8.9B
Q2 25
$8.0B
Q1 25
$7.6B
Q4 24
$7.6B
Q3 24
$7.6B
Q2 24
$7.6B
Q1 24
$6.1B
Stockholders' Equity
GDS
GDS
RPRX
RPRX
Q4 25
$9.7B
Q3 25
$3.6B
$9.6B
Q2 25
$3.4B
$9.5B
Q1 25
$3.2B
$9.8B
Q4 24
$10.3B
Q3 24
$2.7B
$10.3B
Q2 24
$2.6B
$9.8B
Q1 24
$2.6B
$9.9B
Total Assets
GDS
GDS
RPRX
RPRX
Q4 25
$19.6B
Q3 25
$11.0B
$19.3B
Q2 25
$11.1B
$18.3B
Q1 25
$10.1B
$17.6B
Q4 24
$18.2B
Q3 24
$11.7B
$18.0B
Q2 24
$10.9B
$17.7B
Q1 24
$10.5B
$16.1B
Debt / Equity
GDS
GDS
RPRX
RPRX
Q4 25
0.92×
Q3 25
0.93×
Q2 25
0.84×
Q1 25
0.78×
Q4 24
0.74×
Q3 24
0.74×
Q2 24
0.78×
Q1 24
0.62×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
GDS
GDS
RPRX
RPRX
Operating Cash FlowLast quarter
$103.5M
$827.1M
Free Cash FlowOCF − Capex
$-96.3M
FCF MarginFCF / Revenue
-23.7%
Capex IntensityCapex / Revenue
49.2%
Cash ConversionOCF / Net Profit
3.86×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
GDS
GDS
RPRX
RPRX
Q4 25
$827.1M
Q3 25
$103.5M
$702.6M
Q2 25
$120.8M
$364.0M
Q1 25
$596.1M
Q4 24
$742.5M
Q3 24
$91.4M
$703.6M
Q2 24
$658.2M
Q1 24
$664.6M
Free Cash Flow
GDS
GDS
RPRX
RPRX
Q4 25
Q3 25
$-96.3M
Q2 25
$-55.8M
Q1 25
Q4 24
Q3 24
$-321.7M
Q2 24
Q1 24
FCF Margin
GDS
GDS
RPRX
RPRX
Q4 25
Q3 25
-23.7%
Q2 25
-13.8%
Q1 25
Q4 24
Q3 24
-76.1%
Q2 24
Q1 24
Capex Intensity
GDS
GDS
RPRX
RPRX
Q4 25
Q3 25
49.2%
Q2 25
43.6%
Q1 25
Q4 24
Q3 24
97.7%
Q2 24
Q1 24
Cash Conversion
GDS
GDS
RPRX
RPRX
Q4 25
3.86×
Q3 25
2.44×
Q2 25
12.06×
Q1 25
2.50×
Q4 24
3.57×
Q3 24
1.29×
Q2 24
6.45×
Q1 24
139.10×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

GDS
GDS

Service revenue$405.5M100%
Equipment sales$2.8M1%

RPRX
RPRX

Financial Royalty Assets$592.4M95%
Royalty Income Other$29.6M5%

Related Comparisons